Clinical Trial Update: A Study to Evaluate the Efficacy, Safety, and Tolerability of ASC30 Tablets in Participants With Type 2 Diabetes Mellitus [Phase 2]

View source ↗

Summary

This clinical trial is evaluating ASC30 tablets for efficacy, safety, and tolerability in adults with Type 2 Diabetes Mellitus in Phase 2 and is currently recru…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• ASC30 (ASC30)

Snippet

Sponsor: Ascletis Pharma (China) Co., Limited | Conditions: T2DM (Type 2 Diabetes Mellitus) | Phase 2 | Status: RECRUITING